ライフサイエンスコーパス: catheter-associated bloodstream infection

1 pecific ICU infections (e.g., central venous catheter-associated bloodstream infections).

2 ant, sustained reduction in the incidence of catheter-associated bloodstream infection.

3 tepwise interventions on the rate of central catheter-associated bloodstream infections.

4 observed prospectively for the occurrence of catheter-associated bloodstream infections.

5 ly adopted as a means to reduce the risk for catheter-associated bloodstream infections.

6 Secondary outcomes included catheter-associated bloodstream infection and catheter f

7 The incidence of nosocomial catheter-associated bloodstream infection and patient de

8 project produced a 66% reduction in central catheter-associated bloodstream infections and a median

9 hat were targeted by the CMS policy (central catheter-associated bloodstream infections and catheter-

10 08 CMS policy to reduce payments for central catheter-associated bloodstream infections and catheter-

11 a data collection system to monitor central catheter-associated bloodstream infections and other var

12 Device-associated infections (i.e., central-catheter-associated bloodstream infection, catheter-asso

13 We describe three cases of central venous catheter-associated bloodstream infections caused by Dok

14 lure are at high risk for developing central catheter-associated bloodstream infections (CCABSIs) owi

15 iated with an immediate reduction in central catheter-associated bloodstream infections (coefficient

16 Thirty cases of catheter-associated bloodstream infections during 6110 c

17 Central catheter-associated bloodstream infection events identif

18 Patients with catheter-associated bloodstream infection had significan

19 Patients with catheter-associated bloodstream infection had significan

20 o practice at the bedside to prevent central catheter-associated bloodstream infections, improving cu

21 rst case of a successfully treated A. oryzae catheter-associated bloodstream infection in an immunoco

22 We measured occurrence of catheter-associated bloodstream infection, in-hospital m

23 ficant changes in quarterly rates of central catheter-associated bloodstream infections (incidence-ra

24 page, self-study module on the prevention of catheter-associated bloodstream infections, lectures, an

25 Catheter-associated bloodstream infection occurred in 41

26 No catheter-associated bloodstream infection occurred in ei

27 rval (CI): 0.009-0.081; 38 studies), or 4.40 catheter-associated bloodstream infections per 100,000 c

28 Central catheter-associated bloodstream infection prevention bun

29 detected in 2008, which may suggest that the catheter-associated bloodstream infection prevention pro

30 ygiene program, 3) chlorhexidine bathing, 4) catheter-associated bloodstream infection program, and 5

31 bloodstream infections and a median central catheter-associated bloodstream infection rate of zero a

32 report the progressive reduction of central catheter-associated bloodstream infection rates after th

33 Central catheter-associated bloodstream infection rates and safe

34 e-based care in crisis situations, decreases catheter-associated bloodstream infections, reduces bloo

35 s that may affect costs and lengths of stay, catheter-associated bloodstream infections resulted in a

36 nters for electronic surveillance of central catheter-associated bloodstream infections, ventilator-a

37 everity of illness, the attributable cost of catheter-associated bloodstream infection was approximat

38 The origin of each catheter-associated bloodstream infection was sought by

39 The pooled proportion of catheter-associated bloodstream infections was 0.028 % (